| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 21.311 | 31.226 | 33.003 | 23.114 | 28.320 | 30.204 | 33.015 | 28.283 | 29.029 |
| Total Income - EUR | - | 21.311 | 31.226 | 33.003 | 23.125 | 28.320 | 30.204 | 33.015 | 28.283 | 29.029 |
| Total Expenses - EUR | - | 6.091 | 12.340 | 17.687 | 12.590 | 12.407 | 15.207 | 8.814 | 9.970 | 12.387 |
| Gross Profit/Loss - EUR | - | 15.220 | 18.886 | 15.316 | 10.535 | 15.914 | 14.997 | 24.202 | 18.312 | 16.643 |
| Net Profit/Loss - EUR | - | 14.653 | 18.574 | 14.986 | 10.304 | 15.740 | 14.799 | 23.330 | 15.340 | 13.577 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sanomedica Alfamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 13.025 | 9.133 | 5.374 | 1.646 | 0 | 1.791 | 2.098 | 8.196 |
| Current Assets | - | 15.233 | 13.765 | 32.731 | 28.354 | 37.993 | 16.487 | 23.594 | 14.454 | 15.146 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 837 | 958 | 611 | 941 | 751 | 171 | 16.709 | 4.061 | 18 |
| Cash | - | 14.396 | 12.807 | 32.120 | 27.413 | 37.242 | 16.316 | 6.885 | 10.393 | 15.129 |
| Shareholders Funds | - | 14.697 | 26.109 | 40.616 | 33.575 | 38.567 | 14.956 | 23.379 | 15.397 | 13.625 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 654 | 850 | 1.520 | 274 | 1.184 | 1.744 | 2.064 | 1.269 | 10.040 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sanomedica Alfamed S.r.l.